Skip to content

Real world study on Lanqin Granules treating acute upper respiratory tract infection in children

Real world study on Lanqin Granules treating acute upper respiratory tract infection in children

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069186
Enrollment
Unknown
Registered
2023-03-09
Start date
2023-03-09
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute upper respiratory tract infection in children

Interventions

Exposed group:Patients who use Lanqin granules alone or on the basis of conventional western medicine treatment (antibacterial/antiviral drugs, antipyretic and analgesic drugs, antiallergic drugs, ant
Non-exposed group:Non-exposure group: patients who only received conventional treatment with Western medicines (antibacterial/antiviral drugs, antipyretic and analgesic drugs, antiallergic drugs, anti

Sponsors

Yunnan Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with acute upper respiratory tract infection in Western medicine; 2. Aged from 3 to 14 years old; 3. WBS score of pharyngeal pain =4 points; 4. Children with spleen deficiency and loose stool and stomachache were excluded; 5. The informed consent process shall be in compliance with regulations.

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

MeasureTime frame
Time for sore throat to disappear;

Secondary

MeasureTime frame
Rate of disappearance of sore throat;Time for complete remission of fever;Disappearance rate of pharyngeal signs (thirst/hot and dry pharynx, swelling of pharyngeal mucosa, swelling of tonsil);Clinical symptom Grading Scale score;

Countries

China

Contacts

Public ContactMingxi

Yunnan Hospital of Traditional Chinese Medicine

863455756@qq.com13033386907

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026